AddLife AB is a prominent European life science group that acquires and operates specialized companies within the healthcare and research sectors. The company's business model centers on acting as a value-added distributor and service provider, bridging the gap between global manufacturers and end-users such as hospitals, laboratories, and academic institutions. AddLife generates revenue primarily through the resale of medical and laboratory products, complemented by service contracts, installation, and technical support. The company's operations are divided into two main business areas: Medtech and Labtech. The Medtech segment, which accounts for approximately 60% of net sales, supplies medical devices and aids for surgery, orthopedics, critical care, and home adaptation. The Labtech segment, contributing the remaining 40%, focuses on diagnostics, biomedical research, and laboratory analysis, offering analytical instruments, reagents, and consumables. Geographically, AddLife has a strong footprint across Europe, with significant operations in the Nordic region, the UK, Ireland, Spain, and Central Europe. The company's competitive position is bolstered by its decentralized structure of over 85 independent subsidiaries, allowing for deep local market expertise, strong customer relationships, and a continuous strategy of bolt-on acquisitions to expand its niche market presence.
